Nuclear transport and cancer: from mechanism to intervention (original) (raw)

• Akey, C. W. & Radermacher, M. Architecture of the Xenopus nuclear pore complex revealed by three-dimensional cryo-electron microscopy. J. Cell Biol. 122, 1–19 (1993).
  CAS PubMed Google Scholar
• Hinshaw, J. E., Carragher, B. O. & Milligan, R. A. Architecture and design of the nuclear pore complex. Cell 69, 1133–1141 (1992).
  CAS PubMed Google Scholar
• Goldberg, M. W. & Allen, T. D. High resolution scanning electron microscopy of the nuclear envelope: demonstration of a new, regular, fibrous lattice attached to the baskets of the nucleoplasmic face of the nuclear pores. J. Cell Biol. 119, 1429–1440 (1992).
  CAS PubMed Google Scholar
• Stoffler, D., Fahrenkrog, B. & Aebi, U. The nuclear pore complex: from molecular architecture to functional dynamics. Curr. Opin. Cell Biol. 11, 391–401 (1999).
  CAS PubMed Google Scholar
• Miller, B. R. & Forbes, D. J. Purification of the vertebrate nuclear pore complex by biochemical criteria. Traffic 1, 941–951 (2000).
  CAS PubMed PubMed Central Google Scholar
• Cronshaw, J. M., Krutchinsky, A. N., Zhang, W., Chait, B. T. & Matunis, M. J. Proteomic analysis of the mammalian nuclear pore complex. J. Cell Biol. 158, 915–927 (2002).
  CAS PubMed PubMed Central Google Scholar
• Rout, M. P. & Aitchison, J. D. The nuclear pore complex as a transport machine. J. Biol. Chem. 276, 16593–16596 (2001).
  CAS PubMed Google Scholar
• Ryan, K. J. & Wente, S. R. The nuclear pore complex: a protein machine bridging the nucleus and cytoplasm. Curr. Opin. Cell Biol. 12, 361–371 (2000).
  Article CAS PubMed Google Scholar
• Gorlich, D. & Kutay, U. Transport between the cell nucleus and the cytoplasm. Annu. Rev. Cell Dev. Biol. 15, 607–660 (1999). Excellent review on nuclear transport factors and processes.
  Article CAS PubMed Google Scholar
• Mattaj, I. W. & Englmeier, L. Nucleocytoplasmic transport: the soluble phase. Annu. Rev. Biochem. 67, 265–306 (1998).
  CAS PubMed Google Scholar
• Strom, A. C. & Weis, K. Importin-β-like nuclear transport receptors. Genome Biol. 2, REVIEWS3008 (2001).
• Izaurralde, E., Kutay, U., von Kobbe, C., Mattaj, I. W. & Gorlich, D. The asymmetric distribution of the constituents of the Ran system is essential for transport into and out of the nucleus. EMBO J. 16, 6535–6547 (1997).
  CAS PubMed PubMed Central Google Scholar
• Marelli, M., Dilworth, D. J., Wozniak, R. W. & Aitchison, J. D. The dynamics of karyopherin-mediated nuclear transport. Biochem. Cell Biol. 79, 603–612 (2001).
  CAS PubMed Google Scholar
• Uchida, S. et al. Premature chromosome condensation is induced by a point mutation in the hamster RCC1 gene. Mol. Cell. Biol. 10, 577–584 (1990).
  CAS PubMed PubMed Central Google Scholar
• Feldherr, C. M. & Akin, D. Signal-mediated nuclear transport in proliferating and growth-arrested BALB/c 3T3 cells. J. Cell Biol. 115, 933–939 (1991).
  CAS PubMed Google Scholar
• Rayet, B. & Gelinas, C. Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18, 6938–6947 (1999).
  CAS PubMed Google Scholar
• Perkins, N. D. The Rel/NF-kappa B family: friend and foe. Trends Biochem. Sci. 25, 434–440 (2000).
  CAS PubMed Google Scholar
• Karin, M., Cao, Y., Greten, F. R. & Li, Z. W. NF-κβ in cancer: from innocent bystander to major culprit. Nature Rev. Cancer 2, 301–310 (2002).
  CAS Google Scholar
• Henkel, T. et al. Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-κβ subunit. Cell 68, 1121–1133 (1992).
  CAS PubMed Google Scholar
• Beg, A. A. et al. I κβ interacts with the nuclear localization sequences of the subunits of NF-κβ: a mechanism for cytoplasmic retention. Genes Dev. 6, 1899–1913 (1992).
  CAS PubMed Google Scholar
• Ganchi, P. A., Sun, S. C., Greene, W. C. & Ballard, D. W. I κβ/MAD-3 masks the nuclear localization signal of NF-κβ p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding. Mol. Biol. Cell 3, 1339–1352 (1992).
  CAS PubMed PubMed Central Google Scholar
• Chen, L. F. & Greene, W. C. Regulation of distinct biological activities of the NF-κβ transcription factor complex by acetylation. J. Mol. Med. 81, 549–557 (2003).
  CAS PubMed Google Scholar
• Brunet, A. et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857–868 (1999).
  CAS PubMed Google Scholar
• del Peso, L., Gonzalez, V. M., Hernandez, R., Barr, F. G. & Nunez, G. Regulation of the forkhead transcription factor FKHR, but not the PAX3-FKHR fusion protein, by the serine/threonine kinase Akt. Oncogene 18, 7328–7333 (1999).
  CAS PubMed Google Scholar
• Kops, G. J. P. L. et al. Direct control of the forkhead transcription factor AFX by protein kinase B. Nature 398, 630–634 (1999).
  CAS PubMed Google Scholar
• Rena, G., Guo, S., Cichy, S. C., Unterman, T. G. & Cohen, P. Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. J. Biol. Chem. 274, 17179–17183 (1999).
  CAS PubMed Google Scholar
• Takaishi, H. et al. Regulation of nuclear translocation of forkhead transcription factor AFX by protein kinase B. Proc. Natl Acad. Sci. USA 96, 11836–11841 (1999).
  CAS PubMed PubMed Central Google Scholar
• Tang, E. D., Nunez, G., Barr, F. G. & Guan, K. L. Negative regulation of the forkhead transcription factor FKHR by Akt. J. Biol. Chem. 274, 16741–16746 (1999).
  CAS PubMed Google Scholar
• Medema, R. H., Kops, G. J. P. L., Bos, J. L. & Burgering, B. M. T. AFX-like forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27KIP1. Nature 404, 782–787 (2000).
  CAS PubMed Google Scholar
• Nakamura, N. et al. Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol. Cell. Biol. 20, 8969–8982 (2000). FKHR or FOXO1a is mislocalized in PTEN -null cancer cells and reconstitution of FKHR to the nucleus results in cell-cycle arrest or apoptosis.
  CAS PubMed PubMed Central Google Scholar
• Brunet, A. et al. 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. J. Cell Biol. 156, 817–828 (2002).
  CAS PubMed PubMed Central Google Scholar
• Rena, G., Prescott, A. R., Guo, S., Cohen, P. & Unterman, T. G. Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targetting. Biochem. J. 354, 605–612 (2001).
  CAS PubMed PubMed Central Google Scholar
• Maehama, T. & Dixon, J. E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273, 13375–13378 (1998).
  CAS PubMed Google Scholar
• Vazquez, F. & Sellers, W. R. The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling. Biochim. Biophys. Acta 1470, M21–M35 (2000).
  CAS PubMed Google Scholar
• Kondo, K. et al. PTEN/MMAC1/TEP1 mutations in human primary renal-cell carcinomas and renal carcinoma cell lines. Int. J. Cancer 91, 219–224 (2001).
  CAS PubMed Google Scholar
• Kong, D. et al. PTEN1 is frequently mutated in primary endometrial carcinomas. Nature Genet. 17, 143–144 (1997).
  CAS PubMed Google Scholar
• Wang, S. I. et al. Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res. 57, 4183–4186 (1997).
  CAS PubMed Google Scholar
• Brunet, A. et al. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol. Cell. Biol. 21, 952–965 (2001).
  CAS PubMed PubMed Central Google Scholar
• Mazumdar, A. & Kumar, R. Estrogen regulation of Pak1 and FKHR pathways in breast cancer cells. FEBS Lett. 535, 6–10 (2003).
  CAS PubMed Google Scholar
• Rena, G. et al. Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion. EMBO J. 21, 2263–2271 (2002).
  CAS PubMed PubMed Central Google Scholar
• Woods, Y. L. et al. The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site. Biochem. J. 355, 597–607 (2001).
  CAS PubMed PubMed Central Google Scholar
• Biggs, W. H., Meisenhelder, J., Hunter, T., Cavenee, W. K. & Arden, K. C. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc. Natl Acad. Sci. USA 96, 7421–7426 (1999).
  CAS PubMed PubMed Central Google Scholar
• Brownawell, A. M., Kops, G. J., Macara, I. G. & Burgering, B. M. Inhibition of nuclear import by protein kinase B (Akt) regulates the subcellular distribution and activity of the forkhead transcription factor AFX. Mol. Cell. Biol. 21, 3534–3546 (2001).
  CAS PubMed PubMed Central Google Scholar
• Ramaswamy, S. et al. Regulation of G1 progression by the PTEN tumor supressor protein is linked to inhibition of the phosphatidylinositol-3-kinase/Akt pathway. Proc. Natl Acad. Sci. USA 96, 2110–2115 (1999).
  CAS PubMed PubMed Central Google Scholar
• Blain, S. W. & Massague, J. Breast cancer banishes p27 from nucleus. Nature Med. 8, 1076–1078 (2002).
  CAS PubMed Google Scholar
• Liang, J. et al. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nature Med. 8, 1153–1160 (2002).
  CAS PubMed Google Scholar
• Shin, I. et al. PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nature Med. 8, 1145–1152 (2002).
  CAS PubMed Google Scholar
• Viglietto, G. et al. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Nature Med. 8, 1136–1144 (2002). References 46–48 show how p27 phosphorylation by Akt results in p27 nuclear export and cell proliferation.
  CAS PubMed Google Scholar
• Sherr, C. J. & Roberts, J. M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501–1512 (1999).
  CAS PubMed Google Scholar
• Ryan, K. M., Phillips, A. C. & Vousden, K. H. Regulation and function of the p53 tumor suppressor protein. Curr. Opin. Cell Biol. 13, 332–337 (2001).
  CAS PubMed Google Scholar
• Shaulsky, G., Goldfinger, N., Ben-Ze'ev, A. & Rotter, V. Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis. Mol. Cell. Biol. 10, 6565–6577 (1990).
  CAS PubMed PubMed Central Google Scholar
• Liang, S. H., Hong, D. & Clarke, M. F. Cooperation of a single lysine mutation and a C-terminal domain in the cytoplasmic sequestration of the p53 protein. J. Biol. Chem. 273, 19817–19821 (1998).
  CAS PubMed Google Scholar
• Stommel, J. M. et al. A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J. 18, 1660–1672 (1999).
  CAS PubMed PubMed Central Google Scholar
• Zhang, Y. & Xiong, Y. A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation. Science 292, 1910–1915 (2001).
  CAS PubMed Google Scholar
• Tao, W. & Levine, A. J. Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53. Proc. Natl Acad. Sci. USA 96, 3077–3080 (1999).
  CAS PubMed PubMed Central Google Scholar
• Geyer, R. K., Yu, Z. K. & Maki, C. G. The MDM2 RING-finger domain is required to promote p53 nuclear export. Nature Cell Biol. 2, 569–573 (2000).
  CAS PubMed Google Scholar
• Boyd, S. D., Tsai, K. Y. & Jacks, T. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Nature Cell Biol. 2, 563–568 (2000).
  CAS PubMed Google Scholar
• Lohrum, M. A., Woods, D. B., Ludwig, R. L., Balint, E. & Vousden, K. H. C-terminal ubiquitination of p53 contributes to nuclear export. Mol. Cell. Biol. 21, 8521–8532 (2001).
  CAS PubMed PubMed Central Google Scholar
• Gu, J., Nie, L., Wiederschain, D. & Yuan, Z. M. Identification of p53 sequence elements that are required for MDM2-mediated nuclear export. Mol. Cell. Biol. 21, 8533–8546 (2001).
  CAS PubMed PubMed Central Google Scholar
• Harris, C. C. & Hollstein, M. Clinical implications of the p53 tumor-suppressor gene. N. Engl. J. Med. 329, 1318–1327 (1993).
  CAS PubMed Google Scholar
• Moll, U. M., Riou, G. & Levine, A. J. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc. Natl Acad. Sci. USA 89, 7262–7266 (1992).
  CAS PubMed PubMed Central Google Scholar
• Horak, E. et al. Mutant p53, EGF receptor and c-erbB-2 expression in human breast cancer. Oncogene 6, 2277–2284 (1991).
  CAS PubMed Google Scholar
• Moll, U. M., LaQuaglia, M., Benard, J. & Riou, G. Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc. Natl Acad. Sci. USA 92, 4407–4411 (1995).
  CAS PubMed PubMed Central Google Scholar
• Isaacs, J. S., Hardman, R., Carman, T. A., Barrett, J. C. & Weissman, B. E. Differential subcellular p53 localization and function in N- and S-type neuroblastoma cell lines. Cell Growth Differ. 9, 545–555 (1998).
  CAS PubMed Google Scholar
• Flamini, G. et al. Prognostic significance of cytoplasmic p53 overexpression in colorectal cancer. An immunohistochemical analysis. Eur. J. Cancer 32A, 802–806 (1996).
  CAS PubMed Google Scholar
• Runnebaum, I. B., Kieback, D. G., Mobus, V. J., Tong, X. W. & Kreienberg, R. Subcellular localization of accumulated p53 in ovarian cancer cells. Gynecol. Oncol. 61, 266–271 (1996).
  CAS PubMed Google Scholar
• Schlamp, C. L., Poulsen, G. L., Nork, T. M. & Nickells, R. W. Nuclear exclusion of wild-type p53 in immortalized human retinoblastoma cells. J. Natl Cancer Inst. 89, 1530–1536 (1997).
  CAS PubMed Google Scholar
• Moll, U. M. et al. Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage. Mol. Cell. Biol. 16, 1126–1137 (1996).
  CAS PubMed PubMed Central Google Scholar
• Lu, W. et al. Nuclear exclusion of p53 in a subset of tumors requires MDM2 function. Oncogene 19, 232–240 (2000).
  CAS PubMed Google Scholar
• Sengupta, S., Vonesch, J. L., Waltzinger, C., Zheng, H. & Wasylyk, B. Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells. EMBO J. 19, 6051–6064 (2000).
  CAS PubMed PubMed Central Google Scholar
• Nikolaev, A. Y., Li, M., Puskas, N., Qin, J. & Gu, W. Parc: a cytoplasmic anchor for p53. Cell 112, 29–40 (2003). Evidence showing PARC is a cytoplasmic anchor protein and is important in p53 mislocalization by binding and sequestering p53 in the cytoplasm.
  CAS PubMed Google Scholar
• Craig, E., Zhang, Z. K., Davies, K. P. & Kalpana, G. V. A masked NES in INI1/hSNF5 mediates hCRM1-dependent nuclear export: implications for tumorigenesis. EMBO J. 21, 31–42 (2002). First report of an NES masking mechanism for INI1 export.
  CAS PubMed PubMed Central Google Scholar
• Versteege, I. et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394, 203–206 (1998).
  CAS PubMed Google Scholar
• Sevenet, N. et al. Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. Hum. Mol. Genet. 8, 2359–2368 (1999).
  CAS PubMed Google Scholar
• Biegel, J. A. et al. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin. Cancer Res. 8, 3461–3467 (2002).
  CAS PubMed Google Scholar
• Yung, E. et al. Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1. Nature Med. 7, 920–926 (2001).
  CAS PubMed Google Scholar
• Ae, K. et al. Chromatin remodeling factor encoded by ini1 induces G1 arrest and apoptosis in ini1-deficient cells. Oncogene 21, 3112–3120 (2002).
  CAS PubMed Google Scholar
• Versteege, I., Medjkane, S., Rouillard, D. & Delattre, O. A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle. Oncogene 21, 6403–6412 (2002).
  CAS PubMed Google Scholar
• Betz, B. L., Strobeck, M. W., Reisman, D. N., Knudsen, E. S. & Weissman, B. E. Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB. Oncogene 21, 5193–5203 (2002).
  CAS PubMed Google Scholar
• Zhang, Z. K. et al. Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5. Mol. Cell. Biol. 22, 5975–5988 (2002).
  CAS PubMed PubMed Central Google Scholar
• Giles, R. H., van Es, J. H. & Clevers, H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta 1653, 1–24 (2003).
  CAS PubMed Google Scholar
• Polakis, P. Wnt signaling and cancer. Genes Dev. 14, 1837–1851 (2000).
  CAS PubMed Google Scholar
• Henderson, B. R. & Fagotto, F. The ins and outs of APC and β-catenin nuclear transport. EMBO Rep. 3, 834–839 (2002).
  CAS PubMed PubMed Central Google Scholar
• Fabbro, M. & Henderson, B. R. Regulation of tumor suppressors by nuclear-cytoplasmic shuttling. Exp. Cell Res. 282, 59–69 (2003).
  CAS PubMed Google Scholar
• Miyoshi, Y. et al. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum. Mol. Genet. 1, 229–233 (1992).
  CAS PubMed Google Scholar
• Powell, S. M. et al. APC mutations occur early during colorectal tumorigenesis. Nature 359, 235–237 (1992).
  CAS PubMed Google Scholar
• Nagase, H. & Nakamura, Y. Mutations of the APC (adenomatous polyposis coli) gene. Hum. Mutat. 2, 425–434 (1993).
  CAS PubMed Google Scholar
• Rosin-Arbesfeld, R., Cliffe, A., Brabletz, T. & Bienz, M. Nuclear export of the APC tumour suppressor controls β-catenin function in transcription. EMBO. J. 22, 1101–1113 (2003). Indicates that APC truncations might contribute to β-catenin nuclear localization and oncogenesis.
  CAS PubMed PubMed Central Google Scholar
• Yokoya, F., Imamoto, N., Tachibana, T. & Yoneda, Y. β-catenin can be transported into the nucleus in a Ran-unassisted manner. Mol. Biol. Cell 10, 1119–1131 (1999).
  CAS PubMed PubMed Central Google Scholar
• Fagotto, F., Gluck, U. & Gumbiner, B. M. Nuclear localization signal-independent and importin/karyopherin-independent nuclear import of β-catenin. Curr. Biol. 8, 181–190 (1998).
  CAS PubMed Google Scholar
• Malik, H. S., Eickbush, T. H. & Goldfarb, D. S. Evolutionary specialization of the nuclear targeting apparatus. Proc. Natl Acad. Sci. USA 94, 13738–13742 (1997).
  CAS PubMed PubMed Central Google Scholar
• Suh, E. K. & Gumbiner, B. M. Translocation of β-catenin into the nucleus independent of interactions with FG-rich nucleoporins. Exp. Cell Res. 290, 447–456 (2003).
  CAS PubMed Google Scholar
• Neufeld, K. L. et al. Adenomatous polyposis coli protein contains two nuclear export signals and shuttles between the nucleus and cytoplasm. Proc. Natl Acad. Sci. USA 97, 12085–12090 (2000).
  CAS PubMed PubMed Central Google Scholar
• Henderson, B. R. Nuclear-cytoplasmic shuttling of APC regulates β-catenin subcellular localization and turnover. Nature Cell Biol. 2, 653–660 (2000).
  CAS PubMed Google Scholar
• Neufeld, K. L., Zhang, F., Cullen, B. R. & White, R. L. APC-mediated downregulation of β-catenin activity involves nuclear sequestration and nuclear export. EMBO Rep. 1, 519–523 (2000).
  CAS PubMed PubMed Central Google Scholar
• Rosin-Arbesfeld, R., Townsley, F. & Bienz, M. The APC tumour suppressor has a nuclear export function. Nature 406, 1009–1012 (2000).
  CAS PubMed Google Scholar
• Eleftheriou, A., Yoshida, M. & Henderson, B. R. Nuclear export of human β-catenin can occur independent of CRM1 and the adenomatous polyposis coli tumor suppressor. J. Biol. Chem. 276, 25883–25888 (2001).
  CAS PubMed Google Scholar
• Kim, I. S. et al. Truncated form of importin α identified in breast cancer cell inhibits nuclear import of p53. J. Biol. Chem. 275, 23139–23145 (2000). Truncated form of karyopherin-α in breast cancer cells leads to p53 cytoplasmic mislocalization and might contribute to tumorigenesis.
  CAS PubMed Google Scholar
• Brinkmann, U., Gallo, M., Polymeropoulos, M. H. & Pastan, I. The human CAS (cellular apoptosis susceptibility) gene mapping on chromosome 20q13 is amplified in BT474 breast cancer cells and part of aberrant chromosomes in breast and colon cancer cell lines. Genome Res. 6, 187–194 (1996).
  CAS PubMed Google Scholar
• Behrens, P., Brinkmann, U., Fogt, F., Wernert, N. & Wellmann, A. Implication of the proliferation and apoptosis associated CSE1L/CAS gene for breast cancer development. Anticancer Res. 21, 2413–2417 (2001).
  CAS PubMed Google Scholar
• Wellmann, A. et al. High expression of the proliferation and apoptosis associated CSE1L/CAS gene in hepatitis and liver neoplasms: correlation with tumor progression. Int. J. Mol. Med. 7, 489–494 (2001).
  CAS PubMed Google Scholar
• Brinkmann, U., Brinkmann, E., Gallo, M. & Pastan, I. Cloning and characterization of a cellular apoptosis susceptibility gene, the human homologue to the yeast chromosome segregation gene CSE1. Proc. Natl Acad. Sci. USA 92, 10427–10431 (1995).
  CAS PubMed PubMed Central Google Scholar
• Kutay, U., Bischoff, F. R., Kostka, S., Kraft, R. & Gorlich, D. Export of importin α from the nucleus is mediated by a specific nuclear transport factor. Cell 90, 1061–1071 (1997).
  CAS PubMed Google Scholar
• Brinkmann, U., Brinkmann, E., Gallo, M., Scherf, U. & Pastan, I. Role of CAS, a human homologue to the yeast chromosome segregation gene CSE1, in toxin and tumor necrosis factor mediated apoptosis. Biochemistry 35, 6891–6899 (1996).
  CAS PubMed Google Scholar
• Ogryzko, V. V., Brinkmann, E., Howard, B. H., Pastan, I. & Brinkmann, U. Antisense inhibition of CAS, the human homologue of the yeast chromosome segregation gene CSE1, interferes with mitosis in HeLa cells. Biochemistry 36, 9493–9500 (1997).
  CAS PubMed Google Scholar
• Scherf, U., Pastan, I., Willingham, M. C. & Brinkmann, U. The human CAS protein which is homologous to the CSE1 yeast chromosome segregation gene product is associated with microtubules and mitotic spindle. Proc. Natl Acad. Sci. USA 93, 2670–2674 (1996).
  CAS PubMed PubMed Central Google Scholar
• Behrens, P., Brinkmann, U. & Wellmann, A. CSE1L/CAS: its role in proliferation and apoptosis. Apoptosis 8, 39–44 (2003).
  CAS PubMed Google Scholar
• Scherf, U., Kalab, P., Dasso, M., Pastan, I. & Brinkmann, U. The hCSE1/CAS protein is phosphorylated by HeLa extracts and MEK-1: MEK-1 phosphorylation may modulate the intracellular localization of CAS. Biochem. Biophys. Res. Commun. 250, 623–628 (1998).
  CAS PubMed Google Scholar
• Tomiyasu, T., Sasaki, M., Kondo, K. & Okada, M. Chromosome banding studies in 106 cases of chronic myelogenous leukemia. Jinrui Idengaku Zasshi 27, 243–258 (1982).
  CAS PubMed Google Scholar
• Borrow, J. et al. The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9. Nature Genet. 12, 159–167 (1996).
  CAS PubMed Google Scholar
• Nakamura, T. et al. Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia. Nature Genet. 12, 154–158 (1996). References 110 and 111 are the first reports to describe the NUP98–HOXA9 fusion in AML.
  CAS PubMed Google Scholar
• Fornerod, M. et al. Relocation of the carboxy terminal part of CAN from the nuclear envelope to the nucleus as a result of leukemia-specific chromosome rearrangements. Oncogene 10, 1739–1748 (1995).
  CAS PubMed Google Scholar
• Krumlauf, R. Hox genes in vertebrate development. Cell 78, 191–201 (1994).
  CAS PubMed Google Scholar
• Lam, D. H. & Aplan, P. D. NUP98 gene fusions in hematologic malignancies. Leukemia 15, 1689–1695 (2001).
  CAS PubMed Google Scholar
• Kasper, L. H. et al. CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98–HOXA9 oncogenicity. Mol. Cell Biol. 19, 764–776 (1999). Demonstrated that the NUP98–HOXA9 fusion protein has transcriptional activity with p300 and CBP, explaining a possible mode of oncogenicity in AML.
  CAS PubMed PubMed Central Google Scholar
• Radu, A., Moore, M. S. & Blobel, G. The peptide repeat domain of nucleoporin Nup98 functions as a docking site in transport across the nuclear pore complex. Cell 81, 215–222 (1995).
  CAS PubMed Google Scholar
• Kudo, N. et al. Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp. Cell Res. 242, 540–547 (1998).
  CAS PubMed Google Scholar
• Fornerod, M., Ohno, M., Yoshida, M. & Mattaj, I. W. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 90, 1051–1060 (1997).
  CAS PubMed Google Scholar
• Fukuda, M. et al. CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature 390, 308–311 (1997).
  CAS PubMed Google Scholar
• Ossareh-Nazari, B., Bachelerie, F. & Dargemont, C. Evidence for a role of CRM1 in signal-mediated nuclear protein export. Science 278, 141–144 (1997).
  CAS PubMed Google Scholar
• Stade, K., Ford, C. S., Guthrie, C. & Weis, K. Exportin 1 (Crm1p) is an essential nuclear export factor. Cell 90, 1041–1050 (1997). References 118–121 identify CRM1 as the transport receptor for NES-containing cargo proteins.
  CAS PubMed Google Scholar
• Kudo, N. et al. Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc. Natl Acad. Sci. USA 96, 9112–9117 (1999). Demonstrated that LMB covalently modifies CRM1, possibly through a Michael-type addition.
  CAS PubMed PubMed Central Google Scholar
• Akakura, S., Yoshida, M., Yoneda, Y. & Horinouchi, S. A role for Hsc70 in regulating nucleocytoplasmic transport of a temperature-sensitive p53 (p53Val-135). J. Biol. Chem. 276, 14649–14657 (2001).
  CAS PubMed Google Scholar
• Neville, M. & Rosbash, M. The NES-Crm1p export pathway is not a major mRNA export route in Saccharomyces cerevisiae. EMBO J. 18, 3746–3756 (1999).
  CAS PubMed PubMed Central Google Scholar
• Newlands, E. S., Rustin, G. J. & Brampton, M. H. Phase I trial of elactocin. Br. J. Cancer 74, 648–649 (1996).
  CAS PubMed PubMed Central Google Scholar
• Kau, T. R. et al. A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN deficient tumor cells. Cancer Cell 4, 463–476 (2003).
  CAS PubMed Google Scholar